DeepMed Research

MEDICAL COLLEGE OF WISCONSIN

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1893-01-01

Employees: 5K

Market Cap: -

Website: http://www.mcw.edu

Clinical Trials

Effect of Sleep Quality on Hematopoietic Cell Transplant Patient Outcomes

Not Applicable

Terminated

Conditions: Sleep
Multiple Myeloma

Interventions: Behavioral: Sleep Health Information
Behavioral: Mindfulness Awareness Practices for Insomnia

First Posted Date: 2020-02-17

Last Posted Date: 2024-10-09

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 24

Registration Number: NCT04271930

Locations: 🇺🇸
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Order Effects of Prematurity Outcome Data

Not Applicable

Completed

Conditions: Premature Birth

Interventions: Behavioral: Order of pictographs provided to participants
Behavioral: Level of description in survival pictograph

First Posted Date: 2020-02-17

Last Posted Date: 2020-02-17

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 839

Registration Number: NCT04269616

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

A Study of HD-tDCS and Cognitive Training to Improve Cognitive Function in MCI

Not Applicable

Completed

Conditions: Mild Cognitive Impairment
Memory Disorders
Memory Loss

Interventions: Device: sham HD-tDCS combined with CT
Device: HD-tDCS combined with CT

First Posted Date: 2020-01-29

Last Posted Date: 2024-03-22

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 9

Registration Number: NCT04246164

Locations: 🇺🇸
The Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer

Phase 2

Active, not recruiting

Conditions: Invasive Breast Cancer

Interventions: Drug: Cemiplimab
Drug: Paclitaxel
Drug: Carboplatin (not mandatory)
Drug: Doxorubicin
Drug: Cyclophosphamide

First Posted Date: 2020-01-28

Last Posted Date: 2025-02-24

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 36

Registration Number: NCT04243616

Locations: 🇺🇸
Froedtert Hospital & Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients with Renal Insufficiency

Phase 2

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Bortezomib
Drug: Isatuximab
Drug: Cyclophosphamide
Drug: Dexamethasone

First Posted Date: 2020-01-27

Last Posted Date: 2025-01-24

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 41

Registration Number: NCT04240054

Locations: 🇺🇸
Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

PPCM Observational Study (Peripartum Cardiomyopathy)

Conditions: Peripartum Cardiomyopathy
Cardiogenic Shock

Interventions: Device: Clinical placement of a temporary IMPELLA® mechanical circulatory support device.

First Posted Date: 2020-01-21

Last Posted Date: 2021-12-13

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 10

Registration Number: NCT04234659

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Phase 1

Recruiting

Conditions: Chronic Lymphocytic Leukemia (CLL)
Central Nervous System Lymphoma
Non Hodgkin Lymphoma (NHL)
Mantle Cell Lymphoma (MCL)
Follicular Lymphoma
Marginal Zone Lymphoma
Diffuse Large B Cell Lymphoma
Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Interventions: Biological: 8/12-Day Production of Car-T Cells
Biological: 8/12-Day Production of Cryopreserved Car-T Cells
Biological: 12-Day Production of Car-T Cells

First Posted Date: 2019-12-04

Last Posted Date: 2025-02-18

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 100

Registration Number: NCT04186520

Locations: 🇺🇸
Medical College of Wisconsin and Froedtert Hospital, Milwaukee, Wisconsin, United States

Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia

Phase 1

Terminated

Conditions: Acute Myelogenous Leukemia

Interventions: Drug: Azacitidine
Drug: Venetoclax
Drug: Pevonedistat

First Posted Date: 2019-11-21

Last Posted Date: 2024-06-04

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 16

Registration Number: NCT04172844

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Effects of Transcranial Direct Current Stimulation (tDCS) on Language

Not Applicable

Completed

Conditions: Aphasia
Stroke

Interventions: Device: Active Control Transcranial Direct Current Stimulation
Device: Targeted Transcranial Direct Current Stimulation
Behavioral: Semantic-Focused Speech Therapy
Behavioral: Phonologic-Focused Speech Therapy

First Posted Date: 2019-11-18

Last Posted Date: 2025-03-21

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 25

Registration Number: NCT04166513

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit

Not Applicable

Terminated

Conditions: Liver Cirrhoses
ICU Acquired Weakness
Liver Failure

Interventions: Device: Cycle ergometry

First Posted Date: 2019-11-12

Last Posted Date: 2024-03-20

Lead Sponsor: Medical College of Wisconsin

Target Recruit Count: 97

Registration Number: NCT04160039

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy